Literature DB >> 8484776

Activation of MCP-1 gene expression is mediated through multiple signaling pathways.

Y J Shyy1, Y S Li, P E Kolattukudy.   

Abstract

Multiple signal transduction pathways including protein kinase C, tyrosine phosphorylation, and an independent third signaling mechanism are involved in the activation of monocyte chemotactic protein-1 gene. Northern blot analysis showed that the incubation of endothelial cell with dioctanoylglycerol induced maximum level of monocyte chemotactic protein-1 transcripts. The TPA-induced monocyte chemotactic protein-1 expression was abolished by treating the cells with both staurosporine and genistein; however, only a portion of the LPS-induced expression was inhibited by staurosporine/genistein. This is in accordance with the observation that LPS induced the expression of monocyte chemotactic protein-1 in desensitized cells. Thus, a third signal transduction pathway other than protein kinase C or tyrosine kinase is involved in the LPS-induced monocyte chemotactic protein-1 expression in human endothelial cell.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484776     DOI: 10.1006/bbrc.1993.1470

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.

Authors:  S P Lim; A Garzino-Demo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis.

Authors:  K Fuse; M Kodama; H Hanawa; Y Okura; M Ito; T Shiono; S Maruyama; S Hirono; K Kato; K Watanabe; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells.

Authors:  R E Molestina; R D Miller; A B Lentsch; J A Ramirez; J T Summersgill
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Role of macrophage scavenger receptors in hepatic granuloma formation in mice.

Authors:  S I Hagiwara; M Takeya; H Suzuki; T Kodama; L J van der Laan; G Kraal; N Kitamura; K Takahashi
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

5.  Thromboxane A2 (TXA2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells.

Authors:  T Ishizuka; S Sawada; K Sugama; A Kurita
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

6.  Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium.

Authors:  Y J Shyy; H J Hsieh; S Usami; S Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Functional role of the cis-acting elements in human monocyte chemotactic protein-1 gene in the regulation of its expression by phorbol ester in human glioblastoma cells.

Authors:  Y S Li; P E Kolattukudy
Journal:  Mol Cell Biochem       Date:  1994-12-21       Impact factor: 3.396

8.  3',4'-Dihydroxyflavonol down-regulates monocyte chemoattractant protein-1 in smooth muscle: role of focal adhesion kinase and PDGF receptor signalling.

Authors:  F Jiang; N Guo; G J Dusting
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

9.  Cloning and analysis of gene regulation of a novel LPS-inducible cDNA.

Authors:  C G Lee; N A Jenkins; D J Gilbert; N G Copeland; W E O'Brien
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Induction of the gene encoding macrophage chemoattractant protein 1 by Orientia tsutsugamushi in human endothelial cells involves activation of transcription factor activator protein 1.

Authors:  Nam-Hyuk Cho; Seung-Yong Seong; Myung-Sook Huh; Na-Hyun Kim; Myung-sik Choi; Ik-sang Kim
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.